Charles Landis

6.2k total citations · 2 hit papers
62 papers, 2.4k citations indexed

About

Charles Landis is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Charles Landis has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 35 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Charles Landis's work include Hepatitis C virus research (30 papers), Liver Disease Diagnosis and Treatment (27 papers) and Liver Disease and Transplantation (17 papers). Charles Landis is often cited by papers focused on Hepatitis C virus research (30 papers), Liver Disease Diagnosis and Treatment (27 papers) and Liver Disease and Transplantation (17 papers). Charles Landis collaborates with scholars based in United States, Canada and Japan. Charles Landis's co-authors include Fred Poordad, Frank Telang, Charles S. Springer, Xin Li, Eugene R. Schiff, Eugene Swenson, Stephanie Noviello, John M. Vierling, Rong Yang and Eric Hughes and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Charles Landis

60 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence

2016 331 citations Eugene R. Schiff, John M. Vierling et al. Hepatology profile →
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

2019 205 citations Michael Trauner, Aliya Gulamhusein et al. Hepatology profile →

Peers

Countries citing papers authored by Charles Landis

Since Specialization

Citations

This map shows the geographic impact of Charles Landis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Landis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Landis more than expected).

Fields of papers citing papers by Charles Landis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Landis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Landis. The network helps show where Charles Landis may publish in the future.

Co-authorship network of co-authors of Charles Landis

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Landis. A scholar is included among the top collaborators of Charles Landis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Landis. Charles Landis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low-level direct currents eradicate multi-drug-resistant Candidozyma auris through physiological stress and antifungal permeation 2025 ·Chemical Engineering Journal ·C. Royo, Charles Landis, Michael T. Geraghty, (unknown), Tagbo H. R. Niepa	1
2	Factors Associated With Liver Transplant Referral Among Patients With Cirrhosis at Multiple Safety-Net Hospitals 2023 ·JAMA Network Open ·(unknown), Nicole J. Kim, Amy M. Shui, Michele Tana, Charles Landis, (unknown), Saroja Bangaru, Neil Mehta, Kali Zhou	14
3	Rapid detection of hepatitis C virus using recombinase polymerase amplification 2022 ·PLoS ONE ·(unknown), Andrew T. Bender, Lorraine Lillis, (unknown), (unknown), Wynn Burke, Charles Landis, David S. Boyle, Jonathan D. Posner	10
4	Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC 2022 ·Clinical Gastroenterology and Hepatology ·Michael Trauner, Christopher L. Bowlus, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Andrew J. Muir, Andrew N. Billin, Jun Xu, Xiangyu Liu, Xiaomin Lu, Chuhan Chung, Robert P. Myers, Kris V. Kowdley	28
5	Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR 2021 ·Cancers ·Ming‐Lun Yeh, (unknown), Pei‐Chien Tsai, Shu‐Chi Wang, Jennifer Leong, Eiichi Ogawa, Dae Won Jun, Cheng-Hao Tseng, Charles Landis, Yasuhito Tanaka, Chung‐Feng Huang, Jun Hayashi, Yao‐Chun Hsu, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Mindie H. Nguyen, Ming‐Lung Yu	12
6	DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort 2020 ·Journal of Hepatology ·Elizabeth C. Verna, Giuseppe Morelli, Norah A. Terrault, Anna S. Lok, Joseph K. Lim, Adrian M. Di Bisceglie, Stefan Zeuzem, Charles Landis, Paul Y. Kwo, Mohamed A. Hassan, Michael P. Manns, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael Fried, K. Rajender Reddy	81
7	Sofosbuvir plus ribavirin and sofosbuvir plus ledipasvir in patients with genotype 1 or 3 hepatitis C virus and severe renal impairment: a multicentre, phase 2b, non-randomised, open-label study 2020 ·The Lancet. Gastroenterology & hepatology ·Eric Lawitz, Charles Landis, Steven L. Flamm, Maurizio Bonacini, Grisell Ortiz‐Lasanta, Jonathan Huang, Jie Zhang, Brian J. Kirby, Shampa De-Oertel, Robert H. Hyland, Anu Osinusi, Diana M. Brainard, Richard A. Robson, Benedict Maliakkal, Stuart C. Gordon, Edward Gane	21
8	The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC. 2019 ·Hepatology ·Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman, Charles Landis, Bertus Eksteen, Kosh Agarwal, Andrew J. Muir, Simon Rushbrook, Xiaomin Lu, Jun Xu, Jen‐Chieh Chuang, Andrew N. Billin, Chuhan Chung, Georgia Li, G. Mani Subramanian, Robert P. Myers, Christopher L. Bowlus, Kris V. Kowdley	3
9	Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1 2018 ·The Lancet. Gastroenterology & hepatology ·Marc Bourlière, Stuart C. Gordon, Eugene R. Schiff, Tram T. Tran, Natarajan Ravendhran, Charles Landis, Robert H. Hyland, Luisa M. Stamm, Jie Zhang, Hadas Dvory‐Sobol, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Lawrence Serfaty, A. Thompson, Thomas Sepe, Michael P. Curry, K. Rajender Reddy, Michael P. Manns	18
10	Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial 2018 ·Journal of Hepatology ·Gideon M. Hirschfield, Olivier Chazouillères, Joost P.H. Drenth, Douglas Thorburn, Stephen A. Harrison, Charles Landis, Marlyn J. Mayo, Andrew J. Muir, James F. Trotter, Diana Julie Leeming, M.A. Karsdal, Mark Jaros, Lei Ling, (unknown), Stephen J. Rossi, (unknown), Alex M. DePaoli, Ulrich Beuers	147
11	Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis 2018 ·Clinical Gastroenterology and Hepatology ·Joseph K. Lim, (unknown), Mitchell L. Shiffman, Anna S. Lok, Stefan Zeuzem, Norah A. Terrault, James Park, Charles Landis, Mohamed A. Hassan, Joel E. Gallant, Alexander Kuo, Paul J. Pockros, Monika Vainorius, Lucy Akushevich, (unknown), Michael Fried, David R. Nelson, Ziv Ben‐Ari	13
12	Biopsy Specimens From Allograft Liver Contain Histologic Features of Hepatitis C Virus Infection After Virus Eradication 2017 ·Clinical Gastroenterology and Hepatology ·(unknown), Won‐Tak Choi, Keith R. Jerome, Linda Cook, Charles Landis, Joseph Ahn, Helen S. Te, Jamak Modaresi Esfeh, Ibrahim A. Hanouneh, Stephen C. Rayhill, William E. Gibson, Thomas Plesec, Jamie Koo, Hanlin L. Wang, John Hart, Rish K. Pai, Maria Westerhoff	22
13	Safety and efficacy of treatment with once-daily ledipasvir/sofosbuvir (90/400 mg) for 12 weeks in genotype 1 hcv-infected patients with severe renal impairment. 2017 ·Eric Lawitz, Charles Landis, Benedict Maliakkal, (unknown), Grisell Ortiz‐Lasanta, (unknown), Erik Mogalian, Shampa De-Oertel, Anu Osinusi, Diana M. Brainard, John G. McHutchison, (unknown), (unknown), Steven L. Flamm, Stuart C. Gordon, Edward Gane	13
14	Prospective Multicenter Observational Study of Overt Hepatic Encephalopathy 2016 ·Digestive Diseases and Sciences ·Charles Landis, Marwan Ghabril, Vinod K. Rustgi, Adrian M. Di Bisceglie, Benedict Maliakkal, Don C. Rockey, John M. Vierling, Jasmohan S. Bajaj, Richard Rowell, Marco Santoro, Andrés Enríquez, Marzena Jurek, Masoud Mokhtarani, Dion F. Coakley, Bruce F. Scharschmidt	10
15	Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit 2015 ·Gastroenterology ·Feng Su, Lei Yu, Kristin Berry, Iris Liou, Charles Landis, Stephen C. Rayhill, Jorgé Reyes, George N. Ioannou	142
16	Liver Transplantation for Urea Cycle Disorders: Analysis of the United Network for Organ Sharing Database 2015 ·Transplantation Proceedings ·(unknown), Stephen C. Rayhill, Evelyn Hsu, Charles Landis	29
17	The hepatic stem cell niche: Identification by label-retaining cell assay 2008 ·Hepatology ·Reiichiro Kuwahara, Alexander Kofman, Charles Landis, Scott Swenson, E Barendswaard, Neil D. Theise	188
18	Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice 2006 ·Hepatology ·Charles Landis, Kosho Yamanouchi, Hongchao Zhou, Sankar Mohan, Namita Roy‐Chowdhury, David A. Shafritz, Alan P. Koretsky, Jayanta Roy‐Chowdhury, Hoby P. Hetherington, Chandan Guha	21
19	Equilibrium transcytolemmal water-exchange kinetics in skeletal muscle in vivo 1999 ·Magnetic Resonance in Medicine ·Charles Landis, Xin Li, Frank Telang, Patricia E. Molina, (unknown), (unknown), Charles S. Springer	181
20	Equilibrium transcytolemmal water‐exchange kinetics in skeletal muscle in vivo 1999 ·Magnetic Resonance in Medicine ·Charles Landis, Xin Li, Frank Telang, Patricia E. Molina, (unknown), Gábor Vétek, Charles S. Springer	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact